Keyphrases
Protective Immunity
100%
Live Attenuated Vaccine
100%
Attenuated Vaccine Strains
100%
Melioidosis
100%
Pseudomallei
100%
Aerosolized
100%
Burkholderia Pseudomallei
100%
TonB
100%
Hcp1
100%
Full Protection
50%
Causative Agents
25%
Spleen
25%
Liver
25%
Lung
25%
Immune Response
25%
Immunogenicity
25%
Tropics
25%
Protective Efficacy
25%
Humoral Immunity
25%
Treatment Options
25%
Immunization
25%
Live Attenuated
25%
Cell Response
25%
Select Agent
25%
CD4+ T
25%
Etiological Agents
25%
Intracellular Bacteria
25%
C57BL
25%
Vaccination
25%
Pathogenic Bacteria
25%
CD4+
25%
T Helper 17 (Th17)
25%
Vaccine-induced Immunity
25%
Aerosolization
25%
Malleus
25%
Burkholderia Mallei
25%
Limited Treatment
25%
CD8+ T Cells
25%
Severe Infectious Disease
25%
Gram-negative
25%
IgG Antibody
25%
Bacterial Burden
25%
Aerosol Route
25%
Glanders
25%
Aerosol Infection
25%
Immunology and Microbiology
Immunity
100%
Vaccine Efficacy
100%
Live Vaccine
100%
Attenuated Vaccine
100%
Burkholderia pseudomallei
100%
T-Helper Cell
66%
Development
33%
Liver
33%
Spleen
33%
Mouse
33%
Lung
33%
Organisms
33%
C57BL 6 Mouse
33%
Immune Response
33%
Immunogenicity
33%
Infectious Disease
33%
Equus
33%
Humoral Immunity
33%
Wild Type
33%
Bacterial Load
33%
Bacterium
33%
Cytotoxic T-Cell
33%
Immunoglobulin G Antibody
33%
Intracellular Bacterium
33%
Survival
33%
Burkholderia mallei
33%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
100%
Live Vaccine
100%
Vaccine Strain
100%
Melioidosis
100%
Burkholderia pseudomallei
100%
Vaccine
75%
Diseases
25%
Mouse
25%
Immunogenicity
25%
Organisms
25%
Bacterium
25%
Select Agent
25%
Intracellular Bacterium
25%
Survival
25%
Burkholderia mallei
25%
Equus
25%
CD8 Antigen
25%
Immunoglobulin G Antibody
25%
C57BL 6 Mouse
25%
Amoxicillin
25%
Glanders
25%
INIS
strains
100%
immunity
100%
vaccines
100%
protection
50%
mice
33%
aerosols
33%
bacteria
33%
production
16%
antibodies
16%
spleen
16%
diseases
16%
liver
16%
lungs
16%
infectious diseases
16%